9CDS | pdb_00009cds

Crystal structure of OspA ST1 from B. burgdorferi bound to monoclonal antibody LA-2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 
    0.233 (Depositor), 0.226 (DCC) 
  • R-Value Work: 
    0.202 (Depositor), 0.193 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9CDS

This is version 1.1 of the entry. See complete history

Literature

Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.

Finn, M.B.Willsey, G.Piazza, C.L.Clendenen, L.Shrestha, M.You, S.S.Ma, L.Dhingra, Y.Laciak, A.R.Uggowitzer, K.A.Obiero, J.M.Freeman-Gallant, G.Natarajan, H.Green, S.Pirayesh, E.Lai, Y.T.Himansu, S.Carfi, A.Hu, L.T.Mantis, N.Plante, O.Dold, C.

(2026) NPJ Vaccines 

  • DOI: https://doi.org/10.1038/s41541-026-01451-7
  • Primary Citation Related Structures: 
    9CDS

  • PubMed Abstract: 

    Outer surface protein A (OspA) is a ~30 kDa lipoprotein displayed on the surface of Borrelia burgdorferi sensu lato, the etiological agent of Lyme disease. Here we report on the preclinical evaluation of OspA-encoding nucleoside-modified mRNA lipid nanoparticle (OspA mRNA-LNP) vaccines for the prevention of Lyme disease. Crystallographic and binding studies using a panel of transmission-blocking antibodies confirmed that the mRNA-encoded OspA serotype 1 (ST1) expressed in mammalian cells assumes its native structure and retains known protective epitopes. Immunization of mice with OspA ST1 mRNA-LNP elicited functional serum antibodies that promoted spirochete agglutination and complement-dependent borreliacidal activity in vitro. We also examined the impact of combining ST1 OspA mRNA with OspA STs 2-7, which are associated with predominant Borrelia genospecies in Europe (B. garinii, B. afzelii, and B. bavariensis). The additional six STs mRNA did not interfere with ST1 antibody titers and functionality. Finally, mice vaccinated two or three times with different dose levels of OspA ST1 mRNA-LNP or with the heptavalent mRNA vaccine were protected against B. burgdorferi infection in a tick-mediated challenge model. The monovalent and the heptavalent OspA mRNA vaccines (mRNA-1982 and mRNA-1975, respectively) are currently undergoing testing in a Phase 1 clinical trial (NCT05975099).


  • Organizational Affiliation
    • Infectious Disease Research, Moderna, Inc., Cambridge, MA, USA.

Macromolecule Content 

  • Total Structure Weight: 155.74 kDa 
  • Atom Count: 10,807 
  • Modeled Residue Count: 1,341 
  • Deposited Residue Count: 1,432 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Hybridoma Antibody LA2 (Light Chain)
A, D
213Mus musculusMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Hybridoma Antibody LA2 (Heavy Chain)
B, E
213Mus musculusMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
Outer surface protein A
C, F
290Borreliella burgdorferi B31Mutation(s): 0 
Gene Names: ospABB_A15
UniProt
Find proteins for P0CL66 (Borreliella burgdorferi (strain ATCC 35210 / DSM 4680 / CIP 102532 / B31))
Explore P0CL66 
Go to UniProtKB:  P0CL66
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0CL66
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free:  0.233 (Depositor), 0.226 (DCC) 
  • R-Value Work:  0.202 (Depositor), 0.193 (DCC) 
Space Group: P 61
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 68.555α = 90
b = 68.555β = 90
c = 619.736γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateUnited States--

Revision History  (Full details and data files)

  • Version 1.0: 2025-09-24
    Type: Initial release
  • Version 1.1: 2026-08-12
    Changes: Database references